Diagnostic Accuracy of Multiparametric MRI versus TRUS Biopsy in  Clinically Significant Prostate Cancer: Correlation with PSA Derivatives,  Urinary PCA3, and Renal Function

Khawar Ali, Abid Abbas, Shaheen Khan Bahadar, Muhammad Iqbal, Abdur Rasheed, Muhammad Omer

Diagnostic Accuracy of Multiparametric MRI versus TRUS Biopsy in Clinically Significant Prostate Cancer: Correlation with PSA Derivatives, Urinary PCA3, and Renal Function

Authors

Khawar Ali, Abid Abbas, Shaheen Khan Bahadar, Muhammad Iqbal, Abdur Rasheed, Muhammad Omer

Keywords:

Multiparametric MRI; prostate cancer; PSA derivatives; urinary PCA3; renal function.

Abstract

Multiparametric magnetic resonance imaging (mpMRI), transrectal ultrasound (TRUS) biopsy,PSA derivatives, urinary PCA3, and renal function were prospectively evaluated to determine theircollective diagnostic performance in detecting

References

Moore CM, et al. Phase III trial of mpMRI-targeted biopsy vs systematic TRUS biopsy in biopsy-naive men. 2021.

Fang J-H, Zhang L-Q, Xie X, et al. Comparative diagnostic accuracy of mpMRI-US fusion vs systematic biopsy for csPCa. PeerJ. 2023;11:e16614. DOI: 10.7717/peerj.16614

Downloads

Published

2025-08-30

How to Cite

Khawar Ali, Abid Abbas, Shaheen Khan Bahadar, Muhammad Iqbal, Abdur Rasheed, Muhammad Omer. (2025). Diagnostic Accuracy of Multiparametric MRI versus TRUS Biopsy in Clinically Significant Prostate Cancer: Correlation with PSA Derivatives, Urinary PCA3, and Renal Function. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 1656–1661. Retrieved from https://www.ijprt.org/index.php/pub/article/view/945